Angiopoietin-2 and outcome in patients with acute decompensated heart failure

Clinical Research in Cardiology

Volumn 104, Issue 5, 2015, Pages 380-387

  Pöss, Janine ^a,c   Ukena, Christian ^a   Kindermann, Ingrid ^a   Ehrlich, Peter ^a   Fuernau, Georg ^b   Ewen, Sebastian ^a   Mahfoud, Felix ^a   Kriechbaum, Steffen ^a   Böhm, Michael ^a   Link, Andreas ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Acute decompensated heart failure; Angiopoietin 2

Indexed keywords

ANGIOPOIETIN 2; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; CYSTATIN C; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76); TROPONIN T;

ACUTE DISEASE; AGED; BLOOD; BODY MASS; CLINICAL TRIAL; COMPARATIVE STUDY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART FAILURE; HUMAN; LENGTH OF STAY; MALE; METABOLISM; MIDDLE AGED; MORTALITY; PREDICTIVE VALUE; PROGNOSIS; PROSPECTIVE STUDY; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

ACUTE DISEASE; AGED; ANGIOPOIETIN-2; BIOMARKERS; BODY MASS INDEX; CYSTATIN C; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HEART FAILURE; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TROPONIN T;

EID: 84939974121     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-014-0787-y     Document Type: Article

References (23)

1. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Kober L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Ronnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A, Task Force for the D, Treatment of A, Chronic Heart Failure of the European Society of C, Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S, McDonagh T, Sechtem U, Bonet LA, Avraamides P, Ben Lamin HA, Brignole M, Coca A, Cowburn P, Dargie H, Elliott P, Flachskampf FA, Guida GF, Hardman S, Iung B, Merkely B, Mueller C, Nanas JN, Nielsen OW, Orn S, Parissis JT, Ponikowski P, Guidelines ESCCfP (2012) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 14(8):803–869. doi:10.1093/eurjhf/hfs105
2. Reynolds HR, Hochman JS (2008) Cardiogenic shock: current concepts and improving outcomes. Circulation 117(5):686–697. doi:10.1161/CIRCULATIONAHA.106.613596
3. van Meurs M, Kumpers P, Ligtenberg JJ, Meertens JH, Molema G, Zijlstra JG (2009) Bench-to-bedside review: Angiopoietin signalling in critical illness—a future target? Crit Care 13(2):207. doi:10.1186/cc7153
4. Kim I, Kim HG, So JN, Kim JH, Kwak HJ, Koh GY (2000) Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3′-Kinase/Akt signal transduction pathway. Circ Res 86(1):24–29
5. Fiedler U, Reiss Y, Scharpfenecker M, Grunow V, Koidl S, Thurston G, Gale NW, Witzenrath M, Rosseau S, Suttorp N, Sobke A, Herrmann M, Preissner KT, Vajkoczy P, Augustin HG (2006) Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation. Nat Med 12(2):235–239. doi:10.1038/nm1351
6. Fiedler U, Scharpfenecker M, Koidl S, Hegen A, Grunow V, Schmidt JM, Kriz W, Thurston G, Augustin HG (2004) The Tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Palade bodies. Blood 103(11):4150–4156. doi:10.1182/blood-2003-10-3685
7. Scharpfenecker M, Fiedler U, Reiss Y, Augustin HG (2005) The Tie-2 ligand Angiopoietin-2 destabilizes quiescent endothelium through an internal autocrine loop mechanism. J Cell Sci 118(4):771–780. doi:10.1242/Jcs.01653
8. Ong T, McClintock DE, Kallet RH, Ware LB, Matthay MA, Liu KD (2010) Ratio of angiopoietin-2 to angiopoietin-1 as a predictor of mortality in acute lung injury patients. Crit Care Med 38(9):1845–1851. doi:10.1097/CCM.0b013e3181eaa5bf
9. Kumpers P, Nickel N, Lukasz A, Golpon H, Westerkamp V, Olsson KM, Jonigk D, Maegel L, Bockmeyer CL, David S, Hoeper MM (2010) Circulating angiopoietins in idiopathic pulmonary arterial hypertension. Eur Heart J 31(18):2291–2300. doi:10.1093/eurheartj/ehq226
10. Pichiule P, Chavez JC, LaManna JC (2004) Hypoxic regulation of angiopoietin-2 expression in endothelial cells. J Biol Chem 279(13):12171–12180. doi:10.1074/jbc.M305146200
11. Kumpers P, Lukasz A, David S, Horn R, Hafer C, Faulhaber-Walter R, Fliser D, Haller H, Kielstein JT (2008) Excess circulating angiopoietin-2 is a strong predictor of mortality in critically ill medical patients. Crit Care 12(6):R147. doi:10.1186/cc7130
12. Orfanos SE, Kotanidou A, Glynos C, Athanasiou C, Tsigkos S, Dimopoulou I, Sotiropoulou C, Zakynthinos S, Armaganidis A, Papapetropoulos A, Roussos C (2007) Angiopoietin-2 is increased in severe sepsis: correlation with inflammatory mediators. Crit Care Med 35(1):199–206. doi:10.1097/01.CCM.0000251640.77679.D7
13. Ricciuto DR, dos Santos CC, Hawkes M, Toltl LJ, Conroy AL, Rajwans N, Lafferty EI, Cook DJ, Fox-Robichaud A, Kahnamoui K, Kain KC, Liaw PC, Liles WC (2011) Angiopoietin-1 and angiopoietin-2 as clinically informative prognostic biomarkers of morbidity and mortality in severe sepsis. Crit Care Med 39(4):702–710. doi:10.1097/CCM.0b013e318206d285
14. Chong AY, Caine GJ, Freestone B, Blann AD, Lip GY (2004) Plasma angiopoietin-1, angiopoietin-2, and angiopoietin receptor tie-2 levels in congestive heart failure. J Am Coll Cardiol 43(3):423–428. doi:10.1016/j.jacc.2003.08.042
15. Eleuteri E, Di Stefano A, Tarro Genta F, Vicari C, Gnemmi I, Colombo M, Mezzani A, Giannuzzi P (2011) Stepwise increase of angiopoietin-2 serum levels is related to haemodynamic and functional impairment in stable chronic heart failure. Eur J Cardiovasc Prev Rehabil 18(4):607–614. doi:10.1177/1741826710389410
16. Chen S, Guo L, Chen B, Sun L, Cui M (2013) Association of serum angiopoietin-1, angiopoietin-2 and angiopoietin-2 to angiopoietin-1 ratio with heart failure in patients with acute myocardial infarction. Exp Ther Med 5(3):937–941. doi:10.3892/etm.2013.893
17. Link A, Pöss J, Rbah R, Barth C, Feth L, Selejan S, Böhm M (2013) Circulating angiopoietins and cardiovascular mortality in cardiogenic shock. Eur Heart J 34(22):1651–1662. doi:10.1093/eurheartj/ehs487
18. Werdan K, Russ M, Buerke M, Delle-Karth G, Geppert A, Schondube FA, German Cardiac S, German Society of Intensive C, Emergency M, German Society for T, Cardiovascular S, German Interdisciplinary Association of Intensive C, Emergency M, Austrian Society of C, German Society of A, Intensive Care M, German Society of Preventive M, Rehabilitation (2012) Cardiogenic shock due to myocardial infarction: diagnosis, monitoring and treatment: a German-Austrian S3 Guideline. Dtsch Arztebl Int 109(19):343–351. doi:10.3238/arztebl.2012.0343
19. Fiedler U, Augustin HG (2006) Angiopoietins: a link between angiogenesis and inflammation. Trends Immunol 27(12):552–558. doi:10.1016/j.it.2006.10.004
20. Thurston G, Rudge JS, Ioffe E, Zhou H, Ross L, Croll SD, Glazer N, Holash J, McDonald DM, Yancopoulos GD (2000) Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat Med 6(4):460–463. doi:10.1038/74725
21. van der Heijden M, van Nieuw Amerongen GP, Koolwijk P, van Hinsbergh VW, Groeneveld AB (2008) Angiopoietin-2, permeability oedema, occurrence and severity of ALI/ARDS in septic and non-septic critically ill patients. Thorax 63(10):903–909. doi:10.1136/thx.2007.087387
22. Siner JM, Bhandari V, Engle KM, Elias JA, Siegel MD (2009) Elevated serum angiopoietin 2 levels are associated with increased mortality in sepsis. Shock 31(4):348–353. doi:10.1097/SHK.0b013e318188bd06
23. van der Heijden M, Pickkers P, van Nieuw Amerongen GP, van Hinsbergh VW, Bouw MP, van der Hoeven JG, Groeneveld AB (2009) Circulating angiopoietin-2 levels in the course of septic shock: relation with fluid balance, pulmonary dysfunction and mortality. Intensive Care Med 35(9):1567–1574. doi:10.1007/s00134-009-1560-y